Log In
Print
BCIQ
Print
Print this Print this
 

LX1033

  Manage Alerts
Collapse Summary General Information
Company Lexicon Pharmaceuticals Inc.
DescriptionLocally-acting serotonin synthesis inhibitor
Molecular Target Tryptophan hydroxylase 1 (TPH1) (TPH) ; Tryptophan hydroxylase 2 (TPH2)
Mechanism of ActionTryptophan hydroxylase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationIrritable bowel syndrome
Indication DetailsTreat diarrhea-predominant irritable bowel syndrome (IBS-D); Treat irritable bowel syndrome (IBS)
Regulatory Designation

U.S. - Fast Track (Treat diarrhea-predominant irritable bowel syndrome (IBS-D))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today